# Muscle Derived Cell Therapy for Bladder Exstrophy Epispadias Induced Incontinence

> **NCT01011777** · PHASE1 · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 2 (actual)

## Conditions studied

- Bladder Exstrophy
- Urinary Incontinence

## Interventions

- **DRUG:** MDC

## Key facts

- **NCT ID:** NCT01011777
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-01
- **Primary completion:** 2020-01-23
- **Final completion:** 2020-01-23
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Due to participants withdrawal prior to anticipated end of study.
- **Last updated:** 2020-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01011777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01011777, "Muscle Derived Cell Therapy for Bladder Exstrophy Epispadias Induced Incontinence". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01011777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*